Skip to main content
Signal8
LIEBMAN SEYMOUR profile photo

Seymour Liebman

CIK: 0001252287

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

T2 Biosystems, Inc. logo
TTOO

T2 Biosystems, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • T2 Biosystems, Inc. logo
    TTOO

    T2 Biosystems, Inc.

    Nov 4, 2024
    Award(A)

    Restricted Stock Units

    Direct
    25K shares-

1-1 of 1

Seymour Liebman files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO). Signal8 holds 1 reported Form 4/5 transaction by Seymour Liebman since Sep 2024. The most recent reported transaction is a grant / award (Form 4 code A) in TTOO, dated Nov 4, 2024.

About LIEBMAN SEYMOUR

LIEBMAN SEYMOUR (SEC CIK 0001252287) files insider reports with the SEC as Director of T2 Biosystems, Inc. (TTOO).

Signal8 holds 1 ownership filing by LIEBMAN SEYMOUR, a Form 4, filed on Jan 2, 2025. Those filings report 1 transaction, the latest on Nov 4, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on LIEBMAN SEYMOUR's filings is in LEXINGTON, MA.

Recent filings by LIEBMAN SEYMOUR

  • Nov 4, 2024: Grant or award of TTOO derivative securities (Form 4, code A).

Other insiders filing for T2 Biosystems, Inc. (TTOO)

How to read Form 4 transaction codes